{"drugs":["Bitolterol Mesylate","Tornalate"],"mono":{"0":{"id":"79430-s-0","title":"Generic Names","mono":"Bitolterol Mesylate"},"1":{"id":"79430-s-1","title":"Dosing and Indications","sub":{"0":{"id":"79430-s-1-4","title":"Adult Dosing","mono":"<ul><li>Bitolterol mesylate (Tornalate(R)) is no longer available in the United States.<\/li><li><b>Asthma:<\/b> ACUTE BRONCHOSPASM, metered dose inhaler, 2 puffs separated by 1 to 3 min, follow with third as needed<\/li><li><b>Asthma:<\/b> PREVENTION OF BRONCHOSPASM, metered dose inhaler, 2 puffs every 8 h, MAX 3 puffs every 6 hr or 2 puffs every 4 hr<\/li><li><b>Asthma:<\/b> PREVENTION OF BRONCHOSPASM, intermittent flow nebulizer, 0.5 to 1 mL (1 to 2 mg) 3 to 4 times per day, MAX 8 mg\/day; continuous flow nebulizer, 1.25 mL (2.5 mg) 3 to 4 times\/day, MAX 14 mg\/day<\/li><\/ul>"},"1":{"id":"79430-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>Bitolterol mesylate (Tornalate(R)) is no longer available in the United States.<\/li><li><b>Asthma:<\/b> (12 y and older) ACUTE BRONCHOSPASM, metered dose inhaler, 2 puffs separated by 1 to 3 min, follow with third as needed<\/li><li><b>Asthma:<\/b> (12 y and older) PREVENTION OF BRONCHOSPASM, metered dose inhaler, 2 puffs every 8 h, MAX 3 puffs every 6 hr or 2 puffs every 4 hr<\/li><li><b>Asthma:<\/b> (12 y and older) PREVENTION OF BRONCHOSPASM, intermittent flow nebulizer, 0.5 to 1 mL (1 to 2 mg) 3 to 4 times per day, MAX 8 mg\/day; continuous flow nebulizer, 1.25 mL (2.5 mg) 3 to 4 times\/day, MAX 14 mg\/day<\/li><\/ul>"},"3":{"id":"79430-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Bitolterol mesylate (Tornalate(R)) is no longer available in the United States.<\/li><li>Asthma<\/li><\/ul><b>Non-FDA Labeled Indications<\/b><ul><li>Bitolterol mesylate (Tornalate(R)) is no longer available in the United States.<\/li><li>Chronic obstructive pulmonary disease<\/li><\/ul>"}}},"3":{"id":"79430-s-3","title":"Contraindications\/Warnings","sub":[{"id":"79430-s-3-9","title":"Contraindications","mono":"hypersensitivity to bitolterol products<br\/>"},{"id":"79430-s-3-10","title":"Precautions","mono":"<ul><li>cardiovascular disease, hypertension, arrhythmias<\/li><li>concomitant sympathomimetic bronchodilators, epinephrine, monoamine oxidase inhibitors, or tricyclic antidepressants<\/li><li>convulsive disorders<\/li><li>diabetes mellitus<\/li><li>hyperthyroidism<\/li><\/ul>"},{"id":"79430-s-3-11","title":"Pregnancy Category","mono":"Bitolterol: C (FDA)<br\/>"},{"id":"79430-s-3-12","title":"Breast Feeding","mono":"Bitolterol: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"79430-s-4","title":"Drug Interactions","sub":{"1":{"id":"79430-s-4-14","title":"Major","mono":"<ul>Entacapone (theoretical)<\/ul>"}}},"5":{"id":"79430-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Nausea (3%)<\/li><li><b>Neurologic:<\/b>Headache (4%), Tremor (14%)<\/li><li><b>Psychiatric:<\/b>Feeling nervous (5%)<\/li><li><b>Respiratory:<\/b>Cough (4%), Throat irritation (5%)<\/li><\/ul>"},"6":{"id":"79430-s-6","title":"Drug Name Info","sub":{"0":{"id":"79430-s-6-17","title":"US Trade Names","mono":"Tornalate<br\/>"},"2":{"id":"79430-s-6-19","title":"Class","mono":"<ul><li>Beta-2 Adrenergic Agonist<\/li><li>Bronchodilator<\/li><li>Sympathomimetic<\/li><\/ul>"},"3":{"id":"79430-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"9":{"id":"79430-s-9","title":"Administration","mono":"<b>Inhalation<\/b><br\/><ul><li>(aerosol) allow 1-3 min between puffs<\/li><li>(solution) administer nebulized solution over 10 to 15 min; dilute in 2-4 mL of NS<\/li><\/ul>"},"13":{"id":"79430-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause tremor, feeling of nervousness, or throat irritation.<\/li><li>Instruct patient to report needing increased frequency or amounts of drug to provide symptomatic relief.<\/li><li>Advise patient on proper inhalation technique, depending on the delivery device used.<\/li><\/ul>"}}}